These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 28176270)
1. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers. Sun H; Yarovoy I; Capeling M; Cheng C Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270 [TBL] [Abstract][Full Text] [Related]
2. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers. Tsouris V; Joo MK; Kim SH; Kwon IC; Won YY Biotechnol Adv; 2014; 32(5):1037-50. PubMed ID: 24924617 [TBL] [Abstract][Full Text] [Related]
3. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
4. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy. Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735 [TBL] [Abstract][Full Text] [Related]
5. Facile Hydrophobization of siRNA with Anticancer Drug for Non-Cationic Nanocarrier-Mediated Systemic Delivery. Xu C; Li D; Cao Z; Xiong M; Yang X; Wang J Nano Lett; 2019 Apr; 19(4):2688-2693. PubMed ID: 30844291 [TBL] [Abstract][Full Text] [Related]
6. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells. Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325 [TBL] [Abstract][Full Text] [Related]
7. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359 [TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents. Zhao J; Feng SS Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357 [TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059 [TBL] [Abstract][Full Text] [Related]
11. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
12. The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy. Khelghati N; Soleimanpour Mokhtarvand J; Mir M; Alemi F; Asemi Z; Sadeghpour A; Maleki M; Samadi Kafil H; Jadidi-Niaragh F; Majidinia M; Yousefi B Chem Biol Drug Des; 2021 Apr; 97(4):997-1015. PubMed ID: 33458952 [TBL] [Abstract][Full Text] [Related]
13. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo. Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843 [TBL] [Abstract][Full Text] [Related]
14. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review. Tanbour R; Martins AM; Pitt WG; Husseini GA Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742 [TBL] [Abstract][Full Text] [Related]
15. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952 [TBL] [Abstract][Full Text] [Related]
16. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems. Dastgerdi NK; Dastgerdi NK; Bayraktutan H; Costabile G; Atyabi F; Dinarvand R; Longobardi G; Alexander C; Conte C Int J Pharm; 2024 Sep; 663():124545. PubMed ID: 39098747 [TBL] [Abstract][Full Text] [Related]
17. Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy. Jin W; Wang Q; Wu M; Li Y; Tang G; Ping Y; Chu PK Biomaterials; 2017 Jun; 129():83-97. PubMed ID: 28329693 [TBL] [Abstract][Full Text] [Related]
18. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631 [TBL] [Abstract][Full Text] [Related]
19. Cancer Treatment with Liposomes Based Drugs and Genes Co-delivery Systems. Zhang C; Zhang S; Zhi D; Cui J Curr Med Chem; 2018; 25(28):3319-3332. PubMed ID: 29332569 [TBL] [Abstract][Full Text] [Related]
20. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems. Qin X; Li Y Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]